Home/Filings/4/0001181431-10-047126
4//SEC Filing

CHAPLIN DAVID 4

Accession 0001181431-10-047126

CIK 0000908259other

Filed

Sep 16, 8:00 PM ET

Accepted

Sep 17, 2:51 PM ET

Size

5.5 KB

Accession

0001181431-10-047126

Insider Transaction Report

Form 4
Period: 2010-09-15
CHAPLIN DAVID
Chief Scientific Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2010-09-15+200,000200,000 total
    Exercise: $0.28From: 2010-09-15Exp: 2020-09-15Common Stock (200,000 underlying)
Footnotes (1)
  • [F1]The Stock Options vest as follows: (1) 25% vested on the grant date, and (2) the balance will vest in twenty-four equal installments beginning one month from the grant date.

Issuer

OXIGENE INC

CIK 0000908259

Entity typeother

Related Parties

1
  • filerCIK 0001167232

Filing Metadata

Form type
4
Filed
Sep 16, 8:00 PM ET
Accepted
Sep 17, 2:51 PM ET
Size
5.5 KB